Cargando…

Development of Perovskite (MACl)(0.33)FA(0.99)MA(0.01)Pb(I(0.99)Br(0.01))(3) Solar Cells via n-Octylammonium Iodide Surface Passivation

The influence of n-octylammonium iodide (OAI, passive layer) on the types of phases formed in a (MACl)(0.33)FA(0.99)MA(0.01)Pb(I(0.99)Br(0.01))(3) perovskite film was studied using X-ray diffraction. Using UV spectrophotometric techniques, it was determined how varied OAI additive layer ratios affec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osman, M. M., El-naggar, A. M., Alanazi, A. Q., Aldhafiri, A. M., Albassam, A. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179917/ https://www.ncbi.nlm.nih.gov/pubmed/37177037 http://dx.doi.org/10.3390/nano13091492

Ejemplares similares

Magnetic Properties of Novel Layered Disulfides CuCr0.99Ln0.01S2 (Ln = La…Lu)
por: Korotaev, Evgeniy V., et al.
Publicado: (2021)

The Charge Distribution, Seebeck Coefficient, and Carrier Concentration of CuCr(0.99)Ln(0.01)S(2) (Ln = Dy–Lu)
por: Korotaev, Evgeniy V., et al.
Publicado: (2023)

Pressure Dependence of Superconducting Properties, Pinning Mechanism, and Crystal Structure of the Fe(0.99)Mn(0.01)Se(0.5)Te(0.5) Superconductor
por: Murugesan, Kannan, et al.
Publicado: (2021)

Charge Distribution in Layered Lanthanide-Doped CuCr(0.99)Ln(0.01)S(2) (Ln = Pr–Tb) Thermoelectric Materials
por: Korotaev, Evgeniy V., et al.
Publicado: (2022)

Green Synthesis of Mg(0.99) Zn(0.01)O Nanoparticles for the Fabrication of κ-Carrageenan/NaCMC Hydrogel in order to Deliver Catechin
por: Sabbagh, Farzaneh, et al.
Publicado: (2020)

Valence band structure and charge distribution in the layered lanthanide-doped CuCr(0.99)Ln(0.01)S(2) (Ln = La, Ce) solid solutions
por: Korotaev, E. V., et al.
Publicado: (2021)

Origins of Giant Dielectric Properties with Low Loss Tangent in Rutile (Mg(1/3)Ta(2/3))(0.01)Ti(0.99)O(2) Ceramic
por: Thongyong, Nateeporn, et al.
Publicado: (2021)

Novel rare-earth-free yellow Ca(5)Zn(3.92)In(0.08)(V(0.99)Ta(0.01)O(4))(6) phosphors for dazzling white light-emitting diodes
por: Pavitra, E., et al.
Publicado: (2015)

p < 0.05, < 0.01, < 0.001, < 0.0001, < 0.00001, < 0.000001, or < 0.0000001 …
por: Zhu, Weimo
Publicado: (2016)

Structural, electrical, and dielectric study of the influence of 3.4% lanthanide (Ln(3+) = Sm(3+) and La(3+)) insertion in the A-site of perovskite Ba(0.95)Ln(0.034)Ti(0.99)Zr(0.01)O(3)
por: Yahakoub, El Hassan, et al.
Publicado: (2022)

Compounded 0.01% Atropine—What's in the Bottle?
por: Richdale, Kathryn, et al.
Publicado: (2023)

Hybrid Superconducting-Ferromagnetic [Bi(2)Sr(2)(Ca,Y)(2)Cu(3)O(10)](0.99)(La(2/3)Ba(1/3)MnO(3))(0.01) Composite Thick Films
por: Mejía-Salazar, J. Ricardo, et al.
Publicado: (2019)

Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022)

Effectiveness of 0.01% atropine in anisomyopic children
por: Hussain, Azfira, et al.
Publicado: (2023)

Stability of the Structural and Transport Characteristics of (ZrO(2))(0.99−x)(Sc(2)O(3))(x)(R(2)O(3))(0.01) (R–Yb, Y, Tb, Gd) Electrolytic Membranes to High-Temperature Exposure
por: Agarkov, Dmitrii, et al.
Publicado: (2023)

Erbium-doped (Pb(0.9)-Er(0.01)-Zr(0.09)) and (Pb(0.9)-Er(0.01)-Zr(0.045)-Ti(0.045)) nano-crystalline films and nano-rods ceramic synthesis by sol–gel technique for energy-storage application
por: Ibrahim, F. A., et al.
Publicado: (2023)

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
por: Li, Huixia, et al.
Publicado: (2022)

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Theoretical Luminosity Precision for the FCC-ee: Overview of the Path to 0.01%
por: Ward, Bennie F L, et al.
Publicado: (2019)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
por: Chang-Lin, Joan-En, et al.
Publicado: (2011)

Tunable and Passively Mode-Locking Nd(0.01):Gd(0.89)La(0.1)NbO(4) Picosecond Laser
por: Liu, Shande, et al.
Publicado: (2021)

The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
por: Cheng, Ziyun, et al.
Publicado: (2021)

Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023)

Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2022)

Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults
por: Reddy, Vidhatha, et al.
Publicado: (2020)

Enhanced Thermoelectric Properties of Te Doped Polycrystalline Sn(0.94)Pb(0.01)Se
por: Li, Fujin, et al.
Publicado: (2022)

Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2023)

Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020)

Comparison of Skin Antiseptic Agents and the Role of 0.01% Hypochlorous Acid
por: Tran, Ann Q, et al.
Publicado: (2020)

Calibration-free NGS quantitation of mutations below 0.01% VAF
por: Dai, Peng, et al.
Publicado: (2021)

Characteristics of responders to atropine 0.01% as treatment in Asian myopic children
por: Lee, Lung-Chi, et al.
Publicado: (2022)

Reflecting microscope system with a 0.99 numerical aperture designed for three-dimensional fluorescence imaging of individual molecules at cryogenic temperatures
por: Inagawa, H., et al.
Publicado: (2015)

Boron carbide, B(13-x)C(2-y) (x = 0.12, y = 0.01)
por: Sologub, Oksana, et al.
Publicado: (2012)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

A multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2021)

A 0.01-degree gridded precipitation dataset for Japan, 1926-2020
por: Hatono, Misako, et al.
Publicado: (2022)

Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials
por: Myers, Jonathan S, et al.
Publicado: (2014)

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial
por: Cui, Can, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t5vcj8h05sfrmq5538shngrpeh